Dr. Reddy’s Laboratoriesyesterday announced the launch of Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL), in the Usmarket.
Dr. Reddy’s Laboratories along with its subsidiaries, announced the launch of Succinylocholine Chloride Injection USP,200mg/ 10ml (20 mg/ML) Multiple-Dose Vials a therapeutic equivalent generic version of Quelicin (Succinylcholine Chloride) Injection, 20 mg/mL, approved by the U.S. Food and Drug Administration (USFDA).
The Quelicin brand and generic market had U.S. sales of approximately $74.8 million MAT for the most recent twelve months ending in September 2020 according to IQVIA Health.
Dr. Reddy’s Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL), is available in multi-dose vials.